BILE DUCT CANCER

Image

INTRODUCTION

Bile duct cancer, also called cholangiocarcinoma, is a cancer that's found anywhere in the bile ducts. The bile ducts are small tubes that connect different organs. They are part of the digestive system. Early bile duct cancer may not have any symptoms, or they can be hard to spot. It is important to get any symptoms of bile duct cancer checked as soon as possible. Being found late makes bile duct cancer harder to treat. How serious bile duct cancer is and what treatment you have depends on where it is in the bile ducts, how big it is, if it has spread and your general health.

SYMPTOMS

  • Your skin or the whites of your eyes turn yellow (jaundice), you may also have itchy skin, darker. pee, and paler poo than usual.
  • Loss of appetite or losing weight without trying to.
  • Feeling generally unwell.
  • Feeling tired or having no energy.
  • A high temperature, or you feel hot or shivery.

CAUSES

  • Adults over the age of 65.
  • Who have certain medical conditions, such as abnormal bile ducts, long term swelling in the bowel (ulcerative colitis) or bile ducts, a parasite in the liver (liver flukes), bile duct stones and liver cirrhosis.

DIAGNOSIS

  • Blood tests.
  • Scans, like an ultrasound scan (sometimes from inside your body using an endoscope), CT scan, or MRI scan.
  • Collecting a small sample of cells from the bile ducts (called a biopsy) to be checked for cancer
  • A test called an ERCP.
  • A special kind of x-ray called PTC.

TREATMENT

If the cancer has spread too far and cannot be removed, you may have surgery to help control some symptoms of bile duct cancer.

This can include surgery to:

  • Unblock the bile duct or stop it getting blocked, which helps with jaundice.
  • Unblock the first part of the small intestine or stop it getting blocked, which helps with feeling or being sick.
  • Bypass a blockage in the bile duct or small intestine, which helps with jaundice and feeling or being sick.

CONCLUSION

Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

The Journal will publish original articles, reviews, technical notes, editorials, news and views (commentaries, science policy issues, ethical and legal issues, patient organizations, industry needs and alliances, regulatory issues, etc.), and letters to the editor.

The Journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

 The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.

  Media Contact:
ALPINE
Managing Editor

Journal of Molecular Oncology Research
Email: oncology@openaccessjournal.org